China opens the door to Corbion's algae-derived omega-3 DHA
Amsterdam-headquartered sustainable ingredients company Corbion has successfully secured multiple regulatory approvals from China’s General Administration of Customs (GACC), paving the way for offering its algae-derived omega-3 DHA products in China’s human and animal nutrition segments.
The company said it had received several crucial registrations from GACC for the products, marketed under the AlgaPrime DHA and AlgaVia DHA brands, and can now bring them to market in China across both human and animal applications.
“China is an important and fast-growing market for algae-derived omega-3 solutions in both food and feed,” said Tim Rutten, vice president nutrition & pharma at Corbion. “With these registrations and licences in place, we can now offer Chinese customers and partners our proven ingredients that align with their focus on quality, safety, and sustainability.”
Sustainable source
Corbion’s AlgaVia DHA and AlgaPrime DHA deliver a clean, highly concentrated, and sustainable source of omega-3 DHA produced from microalgae via controlled fermentation using sugar cane and renewable energy.
DHA (docosahexaenoic acid) is one of two long-chain fatty acids in omega-3, along with EPA (eicosapentaenoic acid). DHA is crucial for brain and eye development, particularly during pregnancy and early childhood, and is also important for maintaining normal brain and cardiovascular function in adults.
Both DHA and EPA are important for the health of farmed salmon, and AlgaPrime DHA is marketed as an alternative to fish oil in aquafeed. It is produced by growing microalgae in closed fermentation tanks where they transform renewable, sustainable, plant-based sugars into algae containing omega-3-rich biomass in a matter of days.
Corbion’s facility is strategically located among sugar cane fields in Brazil and next door to a sugar cane mill.
